In the wake of the increase in Current Liabilities in the first quarter 2024, Quick Ratio fell to 3.11 below Dermtech Inc average.

Within Medical Laboratories industry 9 other companies have achieved higher Quick Ratio than Dermtech Inc in first quarter 2024. While Quick Ratio total ranking in the first quarter 2024 has deteriorated compared to the prior quarter from 606 to 1262.

Explain Quick Ratio?
How much Cash & cash equivalents DMTK�s has?
What are DMTK�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DMTK Quick Ratio	(Mar 31 2024) Q1	(Dec 31 2023) Q4	(Sep 30 2023) Q3	(Jun 30 2023) Q2	(Mar 31 2023) Q1
Y / Y Current Liabilities Change	-22.43 %	-47.89 %	-25.61 %	6.14 %	11.88 %
Y / Y Cash & cash equivalent Change	-62.8 %	-55.72 %	-54.27 %	-50.4 %	-47.38 %
Quick Ratio MRQ	3.11	6.86	5.4	5.38	6.49
DMTK's Total Ranking	# 1262	# 606	# 608	# 132	#
Seq. Current Liabilities Change	53.63 %	-35.52 %	-21.09 %	-0.77 %	3.21 %
Seq. Cash & cash equivalent Change	-30.23 %	-18.09 %	-20.88 %	-17.73 %	-16.95 %

Quick Ratio first quarter 2024 Company Ranking
Within:	No.
Medical Laboratories Industry	# 10
Healthcare Sector	# 491
Overall Market	# 1262

Quick Ratio Statistics
High	Average	Low
36.95	11.28	0.01
(Mar 31 2021)		(Jun 30 2019)

Financial Statements
Dermtech Inc 's Current Liabilities	$ 13 Millions	Visit DMTK's Balance sheet
Dermtech Inc 's Cash & cash equivalent	$ 39 Millions	Visit DMTK's Balance sheet
Source of DMTK's Sales		Visit DMTK's Sales by Geography

Cumulative Dermtech Inc 's Quick Ratio

DMTK's Quick Ratio for the trailling 12 Months

DMTK Quick Ratio	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months	(Mar 31 2023) 12 Months
Y / Y Current Liabilities TTM Growth	-22.76 %	-14.8 %	2.97 %	23.4 %	42.09 %
Y / Y Cash & cash equivalent TTM Growth	-55 %	-51.4 %	-48.44 %	-44.99 %	-41.21 %
Quick Ratio TTM	5.05	5.95	6.38	7.2	8.67
Total Ranking TTM	# 3810	# 3246	# 3183	# 2703	#
Seq. Current Liabilities TTM Growth	-6.84 %	-12.39 %	-6.72 %	1.45 %	2.76 %
Seq. Cash & cash equivalent TTM Growth	-20.89 %	-18.24 %	-17.36 %	-15.82 %	-14.55 %

Quick ratio ranking by company, industry and sector >> Back to DMTK Financial Strength Comparisons >> Go to Compare DMTK Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in DMTK's Current Liabilities to $12.52 millions, cumulative Quick Ratio to 5.05 below the DMTK average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 43 other companies have achieved higher Quick Ratio than Dermtech Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2023 from 3246 to 3810.

Explain Quick Ratio?
How much Cash & cash equivalents DMTK�s has?
What are DMTK�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Laboratories Industry	# 44
Healthcare Sector	# 1019
Within the Market	# 3810

trailing twelve months Quick Ratio Statistics
High	Average	Low
27.12	10.45	0.06
(Sep 30 2021)		(Jun 30 2019)

Companies with similar Quick Ratio in the quarter ending Mar 31 2024, within Medical Laboratories Industry	Quick Ratio	Mar 31 2024 MRQ Cash & cash equivalent	Mar 31 2024 MRQ Current Liabilities
Omniab Inc	8.14	$ 69.007 Millions	$ 8.474 Millions
Castle Biosciences Inc	7.48	$ 239.213 Millions	$ 31.959 Millions
Butterfly Network Inc	5.35	$ 112.652 Millions	$ 21.047 Millions
Veracyte Inc	4.23	$ 209.188 Millions	$ 49.468 Millions
Bionexus Gene Lab Corp	3.55	$ 5.832 Millions	$ 1.644 Millions
Exagen Inc	3.51	$ 27.267 Millions	$ 7.778 Millions
Dermtech Inc	3.11	$ 38.979 Millions	$ 12.518 Millions
Caredx Inc	3.08	$ 215.921 Millions	$ 70.211 Millions
Personalis Inc	3.04	$ 95.419 Millions	$ 31.373 Millions
Absci Corp	2.89	$ 58.831 Millions	$ 20.352 Millions
Incyte Corporation	2.76	$ 3,850.688 Millions	$ 1,396.453 Millions
Sera Prognostics Inc	2.16	$ 52.973 Millions	$ 24.568 Millions
Burning Rock Biotech Limited	2.16	$ 71.219 Millions	$ 33.037 Millions
Aclarion Inc	1.80	$ 2.133 Millions	$ 1.187 Millions
Bioaffinity Technologies Inc	1.38	$ 2.453 Millions	$ 1.772 Millions
Radnet Inc	1.36	$ 580.477 Millions	$ 427.887 Millions
American Shared Hospital Services	1.21	$ 13.042 Millions	$ 10.779 Millions
Medpace Holdings Inc	1.20	$ 407.010 Millions	$ 339.948 Millions
Exact Sciences Corporation	0.95	$ 652.093 Millions	$ 685.109 Millions
Fulgent Genetics Inc	0.72	$ 54.677 Millions	$ 75.949 Millions

Date modified: 2026-09-26T07:31:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.